C21 Investments Announces Year End Results

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

C21 Investments Announces Year End Results

Canada NewsWire

Strong performance highlighted by Operating Cash Flow up 73%, adjusted EBITDA up 82% Year-over-Year

VANCOUVER, BC, May 27, 2021 /CNW/ - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced unaudited results for its fiscal year ended January 31, 2021. Upon completion of its auditor's internal review process, the Company's audited financials will be filed on SEDAR (www.sedar.com). All currency reported in U.S. dollars (unless otherwise noted).

Fiscal Year Financial Highlights (February 1, 2020 to January 31, 2021):

  • Revenue of $36.1 million – same store sales in Nevada up 6% despite impact of Q1 state-mandated pandemic restrictions
  • Gross Profit of $18.7 million – Gross Margin (before fair value adjustments) of 47%
  • Income from Operations of $7.5 million – a $8.7 million improvement over last year
  • Operating Cash Flow1 of $12.0 million – up 73% over last year – OCF Margin of 33%
  • Working Capital improvement of $27 million
  • Adjusted EBITDA1 of $9.8 million – up 82% over last year

Q4 Highlights (November 1, 2020 to January 31, 2021):

  • Revenue of $9.1 million – same store sales in Nevada up 10% over Q4 last year
  • Gross Profit of $5.5 million – Gross Margin (BFVA) of 54% - up 630 bps over Q3
  • Income from Operations of $3.0 million
  • Operating Cash Flow[1] of $3.8 million – up 21% over Q3
  • Current Liabilities reduced by $19.7 million from last quarter
  • Adjusted EBITDA1 of $2.9 million – up 10% over Q3 – a 32% EBITDA Margin
  • Announced planned cultivation expansion in Nevada – expects to increase canopy and production capacity by 200%
  • Announced divestment of select non-core assets in Oregon
  • Appointed Todd Harrison to the Company's Board of Directors

Management Commentary:

"C21 has delivered strong performance for the fiscal year, generating outsized operating cash flows of $12 million," said Sonny Newman, President and CEO of C21. "We have transformed our balance sheet by eliminating a $27 million working capital deficit. Our relentless focus on execution is clearly delivering results. We have achieved our stated objectives of fortifying our balance sheet and driving efficiency to the bottom line, resulting in significant After-Tax Cash Flow. The evidence is in our numbers. For fiscal 2021, we are reporting an after-tax Operating Cash Flow margin of 25% or C$0.11 per share."

_____________________________

1

 See non-IFRS Measures below for "Adjusted EBITDA", Operating Cash Flow", "After-tax Operating Cash Flow", and "Adjusted Net Income"               

Mr. Newman added, "Our Q4 results represent a baseline for the profitable, scalable business we have built in Nevada. Looking ahead, we are excited with our Nevada cultivation expansion coming online next month. We are in an excellent position to extend our retail footprint as we work with Needham and Company to pursue accretive growth opportunities."

2021 Financial Highlights:

Revenue for the year was $36.1 million, down from $37.7 million, reflecting the impact of the sale of Oregon assets during the period.  Nevada operations delivered record results with $33.5 million in revenue. Same store sales were up 6% despite the Q1 state mandated in-store shutdowns. The Nevada segment generated a 54% Gross Margin for the year and $12.5 million in Net Income Before Tax.

Gross Profit for the year was $18.7 million, with Gross Margin of 47% (before fair value adjustments). Of note, Q4 Gross Margin was a record 54% (BFVA), driven by stronger performance in Nevada and from the divestment of Oregon assets. This delivered $9.8 million of Adjusted EBITDA1 for the year, up 82% year-over-year.

Operating Cash Flow1 of $12.0 million (before working capital changes) was reported for the year, up 73% from 2020. This cash flow generation enabled C21 to pay down $7.0 million of debt in the period as well as $2.8 million of income tax. Cash Provided by Operating Activities (after working capital changes) was $9.9 million, up 68% year-over-year.

C21 reported Income from Operations of $7.5 million for the year, a $8.7 million improvement over last year, driven by stronger gross margins and reduced operating expenses. SG&A expenses were $7.1 million (20% of revenue) down from $10.4 million (28% of revenue) reflecting management's continued focus on driving greater efficiency in its operations.

The Company reported a Net Loss of $6.1 million for the year, which was driven by non-cash accounting items of $10 million, including changes in fair value of derivative liabilities (see MD&A). Excluding these non-cash items, Adjusted Net Income1 was $3.9 million for the fiscal year and $1.7 million for Q4.

The C21 Balance Sheet reflects the results of restructuring activities in Q4. Working capital improved by $27 million with conversion of debentures in the period and the term out of debt obligations over 30 months. Fortifying the balance sheet provides a strong foundation for growth and better access to capital markets.

Cash position at year end was $6.2 million, up from $3.4 million at the end of Q3. Current liabilities were reduced to $15.7 million from $35.4 million at the end of Q3 (see balance sheet summary provided).

Given the strong financial performance reported for FY 2021, management has announced the removal of the going concern note from its audited financial statements.

________________________________

1

See non-IFRS Measures below for "Adjusted EBITDA", "Operating Cash Flow", "After-tax Operating Cash Flow", and "Adjusted Net Income"

Non-IFRS Measures:

"Adjusted EBITDA", "Operating Cash Flow", "After Tax Operating Cash Flow", and "Adjusted Net Income" are supplemental, non-GAAP financial measures. The Company defines EBITDA as earnings before depreciation and amortization (excluding rent classified as lease amortization), income taxes, and interest. Additionally, the Company's Adjusted EBITDA presented above excludes fair value adjustments, accretion, impairment charges, one-time transaction costs and all other non-cash items. The Company has presented "Adjusted EBITDA", "After tax operating cash flow", and "Adjusted net income" because management believes these are useful measures for investors when assessing and considering the Company's continuing operations and prospects for the future. Furthermore, "Adjusted EBITDA" is a commonly used measurement in the financial community when evaluating the market value of similar companies. "Adjusted EBITDA", "After tax operating cash flow", and "Adjusted Net Income" are not measures of performance calculated in accordance with IFRS, and these metrics should not be considered in isolation of, or as a substitute for, the measurement of the Company's performance prepared in accordance with IFRS. "Adjusted EBITDA," as calculated and reconciled in the table above, may not be comparable to similarly titled measurements used by other issuers and is not necessarily a measure of the Company's ability to fund its cash needs.

Fiscal Year End Balance Sheet:


FY 2021

Q3 2021

FY 2020


January 31, 2021

October 31, 2020

January 31, 2020

Assets




Cash

6,237,182

3,402,871

3,076,493

Biological and Inventory

6,758,508

6,353,923

7,600,114

Other current

2,584,431

1,308,042

986,604

Current Assets

15,580,121

11,064,836

11,663,211





Fixed Assets / Goodwill / Intangibles

53,229,388

48,920,007

49,786,874

Total Assets

68,809,509

59,984,843

61,450,085

Liabilities




Accounts payable

2,680,996

3,272,309

3,488,274

Other notes, current lease etc.

3,585,546

4,570,532

3,347,565

Convertible debentures

-

6,574,107

6,867,255

Promissory note

6,080,000

15,800,000

21,200,000

Income tax

3,378,299

5,183,699

3,714,666

Current Liabilities

15,724,841

35,400,647

38,617,760





Other

517,294

3,733,647

1,683,408

Promissory note

8,106,667

-

-

Lease Liabilities

9,691,215

3,210,109

3,870,211

Derivative Liability

9,430,991

3,434,350

3,699,152

Total Liabilities

43,471,008

42,568,644

47,870,531





Equity

25,338,501

17,416,199

13,579,554

Total Liabilities and Shareholder's Equity

68,809,509

59,984,843

61,450,085

Working Capital Deficit

(144,720)

(24,335,811)

(26,954,549)

Financial Summary:


Three Months ended January 31

Twelve Months ended January 31

 (US$ 000's)

Q4 2021

Q4 2020

FY 2021

FY 2020

Revenue

$

9,146

9,512

$

36,127

37,705

Cost of Sales

4,229

5,544

19,053

21,626

Gross Profit (before FV adjustments)

                                                   GM% (BFVA)

4,917

53.8%

3,968*

41.7%*

17,075

47.3%

16,079*

42.6%*

Gross Profit

5,524

2,980

18,652

13,138

Total Expenses

                                      SG&A% of Revenue

2,503

21.3%

2,647  

20.8%  

11,130

19.8%

14,319  

28.1%  

Income (Loss) from Operations

3,020

333

7,522

(1,181)

Net Income (Loss)           

Adjusted Net Income1 (Loss)

(6,582)

1,743   

(21,308)  

NR  

(6,106)

3,949

(32,556)  

NR  

Adjusted EBITDA1

                                                                 EBITDA Margin%

2,890

31.6%

1,776  

18.7%  

9,779

27.1%

5,371  

14.2%  

*Excluding a one-time non-cash accounting charge on the 2019 purchase of Silver State Relief's inventory (see previous fiscal year end MD&A).

Adjusted EBITDA:

Three Months ended January 31

Twelve Months ended January 31


2021

2020

2021

2020






Income (loss) from operations

$ 3,019,987

$ 333,300

$  7,522,313

$  (1,181,107)






Net impact, fair value on
biological assets

(606,964)

803,136

(1,577,550)

2,756,660

Depreciation and amortization

458,285

512,115

2,112,264

3,405,116

Share based compensation

97,327

153,184

494,435

492,631

Inventory Impairment

-

-

1,384,922

-

Lease interest included in
interest expense

(78,155)

(25,534)

(157,201)

(102,133)

 Adjusted EBITDA

$ 2,890,480

$  1,776,201

$9,779,183

$  5,371,167

After-Tax Operating Cash Flow:


Twelve months ended January 31

from Statement of Cash Flows:

2021

2020




Cash Provided by Operating Activities

9,923,724

5,509,864

add back:



Changes in working capital items

2,028,911

1,403,595

Operating Cash Flow1

11,952,635

6,913,459

                                                         OCF Margin%

33.1%

18.3%

Income Tax Expense

(2,922,046)

(3,158,666)




After Tax Operating Cash Flow

9,030,589

3,754,793

                                                     ATOCF Margin%

25.0%

10.0%

                      ATOCF per average share O/S, $C

$0.11

$0.06

 

_________________________

1 

See non-IFRS Measures for "Adjusted EBITDA", "Operating Cash Flow", "After-tax Operating Cash Flow", and "Adjusted Net Income"

About C21 Investments Inc.
C21 Investments is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, and Phantom Farms, Eco Firma Farms in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, additional information on C21 Investments can be found at www.sedar.com and www.cxxi.ca.

Cautionary Statement:

Certain statements contained in this news release may constitute forward-looking statements within the meaning of applicable securities legislation. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward looking statements in this news release include the Company's positioning in the United States cannabis industry, the completion of the Company's auditor's internal review process and timely filing of audited financials, the ability of the Company's Nevada retail locations to operate at record quarterly run rates, the performance of the Company's operations generally, and specifically its Nevada retail operations, during the pendency of the COVID-19 pandemic, the ability of the Company to continue to execute its strategies to improve the Company's Balance Sheet, the progress, timing and expected yield of the Company's Nevada cultivation expansion, the performance of the Company's brands and the continued demand for cannabis products, the ability of the Company to successfully pursue accretive growth, and the nature and extent of the impact of the COVID-19 pandemic. 

The forward-looking statements contained in this news release are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks and uncertainties arising from the impact of the COVID-19 pandemic on the Company's operations, and other factors, many of which are beyond the control of the Company.

The forward-looking statements contained in this news release represent the Company's expectations as of the date hereof and are subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

SOURCE C21 Investments Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/27/c5906.html

Copyright CNW Group 2021

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).